Accueil Procédures Soins aux Aînés Thérapie Accouchement Pays

Choisir la Langue

Prescription Drug Costs (Blue Prescription) in Norway

Tax-Funded Universal Healthcare · Devise : kr (NOK)

Blue Prescription Copay (Max)

520 kr per 3 months

Annual Copay Cap (Frikort)

~3,165 kr

White Prescription

Full price (no subsidy)

Generic Substitution

Mandatory offer

OTC Paracetamol Availability

Pharmacies + stores

Drug Price Regulation

European reference pricing

Aperçu

Norway's prescription drug system features two main categories: blue prescriptions (bla resept) for chronic conditions and white prescriptions for short-term treatments. Blue prescriptions provide substantial subsidies for medications treating long-term and serious conditions such as diabetes, cardiovascular disease, asthma, and mental illness. Under the blue prescription scheme, patients pay a copay of up to 520 kr per prescription per 3-month supply, subject to the annual frikort cap of approximately 3,165 kr.

White prescriptions, used for short-term conditions such as antibiotics for infections, are not subsidized and must be paid in full by the patient. A standard course of antibiotics typically costs 100-300 kr, while other common medications vary widely in price. The Norwegian Medicines Agency (Legemiddelverket) regulates drug prices through a reference pricing system based on the three lowest-priced European countries.

Generic substitution is encouraged in Norway, with pharmacists required to offer generic alternatives when available. The stepped-price model (trinnprismodellen) automatically reduces the reimbursement price of medications when generic alternatives enter the market, achieving significant savings. Norway has among the lowest generic drug prices in Europe due to this system. Over-the-counter medications are available at pharmacies, and a limited selection (primarily paracetamol) can be purchased at grocery stores and gas stations.

Sujets Connexes en Norway

Données provenant de Helsedirektoratet (Norwegian Directorate of Health), Helsenorge.no, Statistisk sentralbyra (SSB), HELFO (Norwegian Health Economics Administration). Dernière mise à jour : 2026-03-01. Ces informations sont à titre éducatif uniquement et ne constituent pas un avis médical.